COVID-19 (Coronavirus)

Janine Bilsborough, PhD

Director, Inflammatory Bowel Disease Drug Discovery & Development

Janine Bilsborough, PhD

Phone:

310-423-7797

Janine Bilsborough, PhD

Director, Inflammatory Bowel Disease Drug Discovery & Development

Janine Bilsborough, PhD, leads the Inflammatory Bowel Disease Drug Discovery and Development unit. This unit, nicknamed 3D, is uniquely positioned to interface with industry partners to aid in discovery of potential therapeutic targets, optimization of successful drug development through patient stratification, and rescue or repurposing of failed drugs through identification of drug-responsive patient populations. The drug discovery and development unit is dedicated to predicting the success of future therapeutics through personalized medicine. Bilsborough has worked in biotech and biopharma for 12 years. Her role in the industry has included directing discovery research and drug development teams in their efforts to develop therapeutics against diseases such as atopic dermatitis, asthma, systemic lupus erythematosus and inflammatory bowel disease. Bilsborough has a PhD in immunology from the University Queensland, Australia, and is focused on the development of successful therapeutics for inflammatory diseases.

  • Doctorate: Queenlsand Institue for Medical Research, 1996
  • Post Doctorate: Ludwigh Institute for Cancer Research, 2000
  • Post Doctorate: Immunex Corporation, 2002

English

Many of the physicians who have medical staff privileges to practice medicine at Cedars-Sinai Medical Center are independent physicians, and not employees or agents of the hospital. These independent physicians bill separately for their services. You should contact your physician to determine their status and billing practices.